The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on July 1, 2026

Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

Indeterminate GlobeNewswire

Jul. 1, 2026

BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

Indeterminate GlobeNewswire

Jul. 1, 2026

Discovery’s New Name Receives TSX Approval

Indeterminate GlobeNewswire

Jul. 1, 2026

Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences

Indeterminate GlobeNewswire

Jul. 1, 2026

First Atlantic Nickel & Cobalt Welcomes Former Director of the Office of Critical Minerals and Metals at the United States Department of Commerce, Gary Stanley, as Senior Strategic Advisor

Indeterminate GlobeNewswire

Jul. 1, 2026

Nova Minerals Appoints Former JP Morgan Metals & Mining Professional to Board as Company Advances U.S. Critical Metals Strategy

Indeterminate GlobeNewswire

Jul. 1, 2026

Quebec Graphite Mine and Processing Plant Prefeasibility Study Confirms Strong Project Economics

Indeterminate GlobeNewswire

Jul. 1, 2026

L’étude de préfaisabilité d’une mine et d’une usine de traitement de graphite au Québec confirme la forte rentabilité du projet

Indeterminate GlobeNewswire

Jul. 1, 2026

Oxford-Harrington Rare Disease Centre Strengthens Rare Childhood Cancer Programme Through Appointment of New Little Princess Trust Professor of Paediatric Oncology

Indeterminate GlobeNewswire

Jul. 1, 2026

Quarterly Report Investor Webinar

Indeterminate GlobeNewswire

Jul. 1, 2026

Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs

Indeterminate GlobeNewswire